Stock QLGN QUALIGEN THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Qualigen Therapeutics, Inc.

Equities

QLGN

US74754R2022

Real-time Estimate Cboe BZX
Other stock markets
 12:19:58 2024-06-27 EDT 		5-day change 1st Jan Change
0.18 USD +7.72% Intraday chart for Qualigen Therapeutics, Inc. +0.68% -67.58%
04-16 Marizyme Enters into Co-Development Agreement with Qualigen Therapeutics for the Commercialization of FDA-Cleared DuraGraft? CI
04-08 Qualigen Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
QUALIGEN THERAPEUTICS, INC. Stock Qualigen Therapeutics, Inc.
 1.05M - - - - -
MODERNA, INC. Stock Moderna, Inc.
 46.93B -
LONZA GROUP AG Stock Lonza Group AG
 39.08B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 38.48B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
 31.01B -
CELLTRION, INC. Stock Celltrion, Inc.
 26.14B
  1. Stock Market
  2. Equities
  3. QLGN Stock
  4. Charts Qualigen Therapeutics, Inc.
  5. Sector Chart